| || |
The more free market in healthcare, the better.
The article says that there may be lower safety standards in these drugs from other countries. So, similar to free trade, what are the unintended consequences? Are we going to be shutting down pharmacies in the U.S. Because we are forcing them to buy higher priced rugs that meet safety specifications that we are allowing imported drugs to not have?
If that is the case, I guess I would rather see a bill that 1, allows drugs to be bought form Canada, AND lowers the safety standards here, so that our pharmacies are dealing with the same product and fair competition when buying and selling these drugs, in order to stay competitive.
Then what are you talking about? These are identical items with vastly different price tags.
Last edited by Neomalthusian; 1st March 2017 at 07:41 PM.
Did you read the article? That is what I was going off of. Maybe there are facilities in Canada producing drugs that don't have the same safety standards that our facilities have here. I don't know. You have heard of separate manufacturing facilities, right?
Pfizer Global Sites | Pfizer: One of the world's premier biopharmaceutical companies
Quite a few different locations around the world, and 79 manufacturing sites back in 2010.